Allergic rhinitis is a common disease of complex inheritance and is characterised by mucosal inflammation caused by allergen exposure. The genetics of closely related phenotypes such as asthma, atopy and to some extend atopic dermatitis has attracted attention in recent years. Genetic reports of allergic rhinitis on the contrary have as yet been most sparse. To identify candidate regions holding genes for allergic rhinitis we performed a total genome-scan on affected sib-pair families. From 100 Danish sib-pair families selected for allergy, families containing sib-pairs matching a phenotype definition of both clinical allergic rhinitis and confirmed specific allergy were chosen. Thirty-three affected sib-pair families qualified for the scan that was undertaken using 446 microsatellite markers. Non-parametric linkage results were obtained from MAPMAKER/SIBS computer program. The study revealed one major candidate region on chromosome 4q24-q27 (LOD=2.83) and eight minor candidate regions 2q12-q33, 3q13, 4p15-q12, 5q13-q15, 6p24-p23, 12p13, 22q13, and Xp21 (LOD=1.04 ± 1.63) likely to contain susceptibility genes for allergic rhinitis. Our findings did not support a previous report of linkage of allergic rhinitis to chromosome 12q14-q24 but they added positive evidence to the asthma and atopy candidate regions 2q33 and 6p23. Further identification of the specific genes involved in allergic rhinitis will give opportunities for improved diagnosis and treatment. European Journal of Human Genetics (2001) 9, 945 ± 952.
Introduction
Rhinitis is a prevalent cause of personal morbidity and a significant contributor to costs of medical treatment. It is characterised by nasal itching and blockage, rhinorrhea and sneezing. Symptoms are in some definitions considered abnormal if lasting for at least 1 h a day on most days. 1 Although sometimes treated with ease, rhinitis often significantly influences a patient's quality of life.
Allergic rhinitis is by far the most common form of rhinitis, affecting 10 ± 30% of adults and up to 40% of children. 2 Genetic factors account for 75% and environmental factors for 25% of disease risk. 3 Allergic rhinitis often affects patients with other co-existing manifestations of allergy such as asthma and atopic dermatitis. Genetic studies of allergy have mainly reported results on asthma or general atopy phenotypes and only a few papers have evaluated allergic rhinitis.
The aim of this study was systematically to search the genome for candidate regions containing genes predisposing to allergic rhinitis. Therefore we undertook a comprehensive genome scan using 446 highly informative markers in thoroughly characterised Danish patient material. Thus, we present here results of the first genome-scan of the phenotype allergic rhinitis. Identification of genes predisposing to allergic rhinitis will not only improve knowledge about the disease pathogenesis but also provide important targets in development of new generations of medication and treatment.
Materials and methods
Patients and participants A total of 424 individuals from 100 Danish nuclear families selected for clinical atopy were enrolled in the Danish allergy project ITA, The Inheritance of Type I Allergy. The families were recruited from the western part of Denmark through one adult and four paediatric outpatient allergy clinics in Aarhus, Herning, Viborg, and Aalborg. All participants, 200 parents and 224 children, were clinically examined and questionnaire tested by the same doctor. They had blood drawn for DNA analysis and for serum measurement of total IgE and specific IgE, RAST, to 11 common allergens. Among the offspring mean age was 10.8 years and male/female sex ratio was 1.2 equivalent to random distribution (P=0.35). The ITA-project was carried out in accordance with the Helsinki declaration and approved by the Danish scientific ethical committee system. All participants and/or their parents gave informed consent.
Phenotype definition
To perform the total genome scan, families holding at least two full siblings with clinical allergic rhinitis and elevated specific IgE against at least one of the tested allergens, RAST 51+, were selected. The use of a narrow phenotype has been discussed earlier. 4 The specific IgE measurements, CAP RAST FEIA (Pharmacia, Uppsala, Sweden), were elevated when 50.35 kUA/l (5class 1) and determined for 11 allergens: grass, birch, mugworth, olive, Parietaria, cat, dog, horse, mite (D. pteronyssinus and D. farinae) and Cladosporium herbarum. Allergic rhinitis was diagnosed according to standard criteria 2 and determined by two separate doctors ± first by one doctor doing all the interviews and examinations of the allergy families in the outpatient clinic and second by one doctor evaluating the questionnaires only. The agreement on the clinical diagnosis was high (498 %), in the few cases of discrepancies the questionnaires were re-evaluated by the same two physicians and consensus was obtained. A total of 33 ITA sib-pair families qualified for the genome scan on allergic rhinitis on these conditions (Table 1) .
Molecular genetics
A comprehensive set of 446 highly informative microsatellite markers (http://www.marshmed.org/genetics/) scattered with a mean distance of 7.85 cM (range: 0 ± 16.71 cM) throughout the 22 autosomal chromosomes and the X chromosome were selected. The markers were purchased as scan primers (DNA Technology, Aarhus, Denmark). PCR conditions were optimised to make all primers perform in a multiplex PCR with one to six (mean=3.5) primer sets. Products were analysed in 47 panels of four to fourteen primer sets; the separation and genotyping were made on an ABI 310 Genetic Analyzer (Perkin Elmer, Foster City, CA, USA).
Statistical analysis
The data from the allergic rhinitis affected sib-pair families were analysed by non-parametric multipoint linkage analysis using the maximum-likelihood-score (MLS) approach. 5 The computer program MAPMAKER/SIBS 6 was used for calculation of maximum likelihood IDB (identical-by-decent), exclusion LOD scores and information content. To extract the extra information from families with more than two affected siblings we used the MAPMAKER/SIBS program facility to calculate data based on both independent sib-pairs and non-weighted all sib-pairs. Maximum likelihood and exclusion calculations allowed for dominance variance. An increment step setting of five facilitated computing of LOD scores in a total of 2345 positions. Multipoint exclusion maps were obtained for disease susceptibility models with l s of 1.2, 1.5, 2, 3, 5, and 10.
Results
We found linkage of allergic rhinitis to the region 4q24-q27 by a LOD score of 2.83 when computing data using the more conservative independent sib-pairs setting. When we repeated the calculations using the all sib-pairs mode the LOD score was 3.26. Another eight regions, 2q12-q33, 3q13, 4p15-q12, 5q13-q15, 6p24-p23, 12p13, 22q13, and Xp21, showed evidence of linkage detected by LOD scores in the range of 1.04 ± 1.63. The LOD scores rose in the regions 12p13 and Xp21 to 1.88 and 1.61, respectively, when all sib-pairs calculations were used. Results of the multipoint linkage analysis through out the genome are shown as plots by chromosome (Figure 1 ). Specific data from the nine regions with LOD 41 are given (Table 2) . Information content reflects both marker density and marker heterozygosity and is useful in predicting the quality of the marker map by means of providing exhaustive information in the sample tested. The information content mean value in the nine appointed regions (Table 2 ) was 0.77 (range 0.44 ± 0.95). Exclusion LOD scores assuming l s =3 and 5 were exclusive (LOD 572) for 35% and 63% of the genome, respectively. No evidence of linkage was found to either of the atopy candidate genes, TNF-b and FcER1b, or to the Il4R-region.
Discussion
Over the past decade intensive research in the complex genetics of allergy has generated numerous reports of linkage and association. The majority of studies have evaluated the phenotypes asthma and atopy, a few have focused on atopic dermatitis, and only one paper has reported data on allergic rhinitis. 7 The genetic model for allergic disease still remains to be determined, but a combination of general allergy genes and organ specific genes has been suggested. 7 ± 9 In the present study we evaluated the clinical phenotype allergic rhinitis combined with documented type I allergy, RAST 51+. The narrow phenotype definition was used in attempt to decrease the genetic heterogeneity and thereby increase the power of the study. 4 Evidence of linkage between allergic rhinitis and the markers D4S1651 and D4S2394 defined a candidate region of approximate 13 cM that may harbour a specific susceptibility gene, since the region is novel, also in the general family of potential allergy candidate regions. When observing the allele-sharing pattern in the region the genetic contribution was most consistent with dominant inheritance. Among the other eight regions showing evidence of linkage two regions were supportive of previous findings in chromosome 2q33 10 and 6p23 10 ± 14 regarding the phenotypes asthma and atopy. We did not find evidence of linkage to an earlier reported allergic rhinitis candidate region 12q14-q24, 15 the markers D12S375, D12S1052 and D12S326 (chromosome 12 locus 11 ± 13) all gave LOD scores of 0.00. Genetic heterogeneity and the mode of sampling may explain this clear divergence between the two studies. In the previous study the families were collected in Barbados and primarily selected for the asthma phenotype. Further more we tested three general atopy candidate genes, the TNFb (chromosome 6 locus 6), the FcER1b (chromosome 11 locus 9) and the Il-4 receptor alpha-subunit region between locus 7 ± 8 on chromosome 16, and LOD scores of 0.13, 0.06 and 0.41, respectively, gave no support for linkage. Interpretation of data from a genome-scan calls for awareness of increased risk of false-positive results due to multiple testing. A statistical significance level for a genomewide search with a genome-wide false-positive rate 45% is a LOD score of 4.0 (P=0.00002) has been recommended when using at dense markermap. 16 Simulation studies have shown, that if no susceptibility locus is present in the genome, a LOD score 52.3 (P40.001) will occur by chance somewhere in the genome with a probability of 0.8. 6 Consequently, LOD scores in the range of 2 ± 3 in new candidate regions must be regarded with some caution, until further evidence has been provided. A closer analysis of this region is ongoing. In conclusion, we sampled a thoroughly described clinical set of allergy-sib-pair families and conducted the first genomescan in search for allergic rhinitis candidate genes. Narrow phenotype definition and a comprehensive set of 446 highly informative markers were used. One candidate region of suggestive significance for allergic rhinitis on chromosome 4q24-q27 was identified by conservative statistical analysis. Moreover, we found evidence supporting an additional eight regions. Our future research will be dedicated fine-scale mapping and investigation of candidate genes in the appointed region.
